Table 1 Clinicopathological characteristics of patients enrolled in this study
From: Expression of serum amyloid A in uterine cervical cancer
Characteristics | RT-PCR | IHC | ELISA | |||
|---|---|---|---|---|---|---|
| Â | Number | Percentage (%) | Number | Percentage (%) | Number | Percentage (%) |
Histological type | Â | Â | Â | Â | Â | Â |
 Adenocarcinoma | 2 | 6.4 | 4 | 19.0 | 6 | 4.3 |
 Squamous cell carcinoma | 19 | 61.3 | 12 | 57.1 | 66 | 47.8 |
 CIN |  | 0 |  | 0 | 34 | 24.6 |
 Uterine fibroids | 10 | 32.3 | 5 | 23.9 | 21 | 15.2 |
 Endometrial polyps |  | 0 |  | 0 | 5 | 3.6 |
 Ovarian cysts |  | 0 |  | 0 | 6 | 4.3 |
Grade of tumor | Â | Â | Â | Â | Â | Â |
 Well differentiated | 2 | 9.5 | 4 | 25 | 19 | 26.4 |
 Moderately differentiated | 2 | 9.5 | 5 | 31.3 | 11 | 15.3 |
 Poorly differentiated | 17 | 81.0 | 7 | 43.7 | 42 | 58.3 |
Histological stage | Â | Â | Â | Â | Â | Â |
 CINI |  |  |  |  | 1 | 2.9 |
 CINII |  |  |  |  | 5 | 14.7 |
 CINIII |  |  |  |  | 28 | 82.4 |
FIGO stage (Pre-NAC) | Â | Â | Â | Â | Â | Â |
 Ia |  | 0 | 2 | 12.5 | 3 | 4.1 |
 Ib | 12 | 57.1 | 6 | 37.5 | 30 | 41.7 |
 IIa | 6 | 28.6 | 5 | 31.3 | 30 | 41.7 |
 IIb | 3 | 14.3 | 3 | 18.7 | 9 | 12.5 |
Lymph node metastasis | Â | Â | Â | Â | Â | Â |
 Negative | 10 | 47.6 | 5 | 31.3 | 21 | 29.2 |
 Positive | 11 | 52.4 | 11 | 68.7 | 51 | 70.8 |